These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17095916)

  • 21. The cardiovascular dysmetabolic syndrome.
    Fagan TC; Deedwania PC
    Am J Med; 1998 Jul; 105(1A):77S-82S. PubMed ID: 9707273
    [No Abstract]   [Full Text] [Related]  

  • 22. Hyperlipidemia and cardiovascular disease.
    Kuller LH
    Curr Opin Lipidol; 2007 Apr; 18(2):230-3. PubMed ID: 17353673
    [No Abstract]   [Full Text] [Related]  

  • 23. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B; Maes M; Zambon A
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen protection, oxidized LDL, endothelial dysfunction and vasorelaxation in cardiovascular disease: New insights into a complex issue.
    Subah Packer C
    Cardiovasc Res; 2007 Jan; 73(1):6-7. PubMed ID: 17156767
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypertension and hyperlipidemia].
    Hansen HS; Larsen ML
    Ugeskr Laeger; 2009 Jun; 171(24):2028-30. PubMed ID: 19523369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid profile, low-density lipoprotein oxidation and ceruloplasmin in the progeny of families with a positive history of cardiovascular diseases and/or hyperlipidemia.
    Makedou KG; Mikhailidis DP; Makedou A; Iliadis S; Kourtis A; Vavatsi-Christaki N; Papageorgiou GE
    Angiology; 2009; 60(4):455-61. PubMed ID: 19648144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bibliography. Hyperlipidaemia and cardiovascular disease. Current world literature.
    Curr Opin Lipidol; 2012 Aug; 23(4):386-91. PubMed ID: 22801387
    [No Abstract]   [Full Text] [Related]  

  • 28. Current world literature.
    Curr Opin Lipidol; 2011 Aug; 22(4):308-10. PubMed ID: 21743305
    [No Abstract]   [Full Text] [Related]  

  • 29. Postprandial hyperlipidemia.
    Gotto AM; Patsch J; Yamamoto A
    Am J Cardiol; 1991 Jul; 68(3):11A-12A. PubMed ID: 1853843
    [No Abstract]   [Full Text] [Related]  

  • 30. [Detection and therapeutic correction of hereditary hyperlipidemia: example of an underestimation of absolute priority].
    de Gennes JL
    Therapeutique; 1972 Feb; 48(2):131-3. PubMed ID: 5049322
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperlipidaemia and cardiovascular disease.
    Le NA
    Curr Opin Lipidol; 2002 Oct; 13(5):577-80. PubMed ID: 12352022
    [No Abstract]   [Full Text] [Related]  

  • 32. Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro.
    Rashid I; van Reyk DM; Davies MJ
    FEBS Lett; 2007 Mar; 581(5):1067-70. PubMed ID: 17316626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperlipidemia and cardiovascular disease.
    Le NA
    Curr Opin Lipidol; 1997 Apr; 8(2):U22-4. PubMed ID: 9183555
    [No Abstract]   [Full Text] [Related]  

  • 34. Common questions in managing hyperlipidemia.
    Rosen IM; Sams RW
    Prim Care; 2006 Dec; 33(4):903-21. PubMed ID: 17169673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex differences in oxidative stress and the impact on blood pressure control and cardiovascular disease.
    Sartori-Valinotti JC; Iliescu R; Fortepiani LA; Yanes LL; Reckelhoff JF
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):938-45. PubMed ID: 17645644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR; Gokce N
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atherosclerosis: cell biology and lipoproteins.
    Wahle KW; Heys SD
    Curr Opin Lipidol; 2008 Aug; 19(4):435-7. PubMed ID: 18607194
    [No Abstract]   [Full Text] [Related]  

  • 39. In vivo markers of oxidative stress and therapeutic interventions.
    Tsimikas S
    Am J Cardiol; 2008 May; 101(10A):34D-42D. PubMed ID: 18474272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiovascular pathology in different types of primary hyperlipemias (apropos of 20 cases)].
    Yáñez Polo MA; Rojas Rodríguez J; Causse Prado M; Soriguer Escofet FC; Lissen Otero E; Camacho Laraña P; De la Iglesia Huerta A
    Rev Esp Cardiol; 1972; 25(1):59-67. PubMed ID: 5038566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.